Responses
Cardiovascular and metabolic risk
The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
Compose a Response to This Article
Other responses
No responses have been published for this article.